Navigation Links
Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
Date:6/28/2011

CRANBURY, N.J., June 28, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).

The multicenter study is a placebo-controlled, randomized, parallel group, dose-finding trial that will test three dose levels of subcutaneously administered bremelanotide in premenopausal women diagnosed with female sexual arousal disorder (FSAD) and/or hypoactive sexual desire disorder (HSDD).

The study is expected to enroll 400 premenopausal women across 40 sites within the U.S. and Canada, with a target of randomizing 100 patients to each of three treatment arms and a placebo arm.  Patients will undergo 16 weeks of treatment.

The objective of the Phase 2b trial is to measure safety and efficacy of subcutaneous doses intended for on-demand, home use.  The primary efficacy endpoint is change from baseline to end of study in the number of satisfying sexual events (SSE).

"We are very excited to have begun patient enrollment for the Phase 2b study of bremelanotide, the most advanced on-demand investigational treatment for FSD.  Pending successful completion of the trial, the data will be used to support discussions with the FDA prior to initiation of Phase 3 studies," stated Carl Spana, Ph.D., President & CEO of Palatin.  "We believe bremelanotide has the potential to transform the treatment of patients with FSD, an area of significant unmet need."

Results from this study are anticipated in the second half of calendar year 2012 and will guide the final design of anticipated Phase 3 studies.  For more information on the clinical trial, please vi
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
2. Palatin Technologies, Inc. March 31, 2011 Quarter Results; Teleconference and Webcast to be Held on May 16, 2011
3. FDA Clears Palatin Technologies IND Filing to Commence Clinical Studies for Asthma
4. Palatin Technologies, Inc. Closes $23 Million Public Offering
5. Palatin Technologies Listing Compliance Plan Accepted by NYSE Amex
6. Palatin Technologies Receives Non-Compliance Letter from NYSE Amex
7. Palatin Technologies to Present at 9th Annual BIO Investor Forum
8. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
9. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
10. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
11. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Inc. (NASDAQ: IDXX ) today reported that ... versus the prior year period to $390 million. Organic ... 2014 versus the prior year period was 9%, or ... Earnings per diluted share ("EPS") for the quarter ended ... period to $1.10."In the second quarter, we continued to ...
(Date:7/25/2014)... 2014 NOT FOR RELEASE, PUBLICATION OR ... INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD ... SUCH JURISDICTION AbbVie (NYSE: ABBV ) today announced ... "This was another very strong quarter for ... our original guidance and announced plans to merge with Shire, ...
(Date:7/24/2014)... July 24, 2014  Parnell Pharmaceuticals Holdings Ltd ... will be added to Parnell,s already extensive pipeline ... Ltd, a biotechnology company. The compounds now known ... promise in bone regeneration and dermal regeneration, respectively. ... compounds for the veterinary market with the potential ...
Breaking Medicine Technology:IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3
... SOMERSET, N.J., Dec. 5 Alfacell Corporation (Nasdaq: ... Administration (FDA) has scheduled a pre-NDA meeting date at the ... submission of the final components of the ONCONASE rolling New ... (UMM) patients. The pre-NDA meeting is an important step ...
... Vaccine Program , , ... GNVC ) announced today that the company will ... Society of Tropical Medicine and Hygiene (ASTMH) 57th Annual ... on December 7-11, 2008. Two presentations, highlighting research conducted ...
Cached Medicine Technology:Alfacell Provides ONCONASE(R) NDA Submission Update 2Alfacell Provides ONCONASE(R) NDA Submission Update 3Alfacell Provides ONCONASE(R) NDA Submission Update 4GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting 2GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting 3
(Date:7/26/2014)... July 26, 2014 As the ... the true vision of Xoçai is ... its exclusive and healthy chocolate products. One such ... of cacao, açaí berries and blueberries, an ingredient ... high-antioxidant blend is utilized in all of Xoçai ...
(Date:7/25/2014)... 2014 2014 Deep Research Report ... Industry” is a professional and in-depth research ... market. The report provides basic Laser Scanning ... Microscope definition, classification, application, and industry chain ... covers international market analysis, including China’s domestic market ...
(Date:7/25/2014)... 2014 As reported by the Statesman Journal ... Heroin (7/20), police in Salem, MA as well as ... the recent heroin epidemic that has taken many lives during ... heroin-related overdose case in which police were able to make ... phone. By pretending to be the victim and claiming to ...
(Date:7/25/2014)... America (GSA) the nation,s largest interdisciplinary ... has chosen Heather M. Young, PhD, RN, FAAN, ... 2014 recipient of the Doris Schwartz Gerontological Nursing ... GSA,s Health Sciences Section, is given to a ... and sustained contribution to gerontological nursing research. , ...
(Date:7/25/2014)... Florida Hospital and MOSI officially announced a transformational partnership ... come and make a difference in the Tampa Bay community. ... to provide the support needed to keep the science center ... the IMAX Dome Theatre from film to a state-of-the-art digital ... Theatre in the state of Florida, and it is one ...
Breaking Medicine News(10 mins):Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4Health News:Multiple States Crack Down on Heroin Epidemic 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4
... , ... keep a notebook of surgical cases on the iPhone or iPod touch. Pop up menu’s and ... the busy medical provider. , ... 3, 2009 -- I-Surgery , a new iPhone application for surgery, can be used by ...
... ... shown that sleep deprivation can raise blood pressure as well as increase the risk ... risks while increasing the quality of sleep. , ... Phoenix, AZ (Vocus) December 3, 2009 -- Two sleep ...
... ... anytime, anywhere, is now available. , ... (PRWEB) December 3, 2009 -- It still blazes across news channels, web sites and ... of H1N1 influenza A (swine flu) . Reports of vaccine shortages and long lines ...
... , , McALLEN, Texas, ... ENSG ), announced today that it has acquired three ... & Healthcare Center in McAllen, the 100-bed Alta Vista ... Rehabilitation & Healthcare in Harlingen. The acquisitions were effective ...
... GRAND RAPIDS, Mich., Dec. 3 Van Andel Research Institute ... acid (ABA) works at the molecular level to help plants ... Their findings, published in the journal Nature , could ... world and combat global food shortages. The findings could ...
... , NEW YORK, Dec. 2 Reportlinker.com ... its catalogue: , Renal Disease Treatments: Products and Therapies ... market in products and services, providing data for 2008 and ... annual growth rates (CAGRs) from 2009 to 2014 , ...
Cached Medicine News:Health News:Treadmill Desks Lower Health Risks Caused by Lack of Sleep 2Health News:Finally, Some Good News about Swine Flu 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 3Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10
... minimal cervical spine manipulation. Prevent dental and ... Cost effective alternative to X-ray. Light-guided intubation ... soft tissues in the neck. This technique ... the trachea relative to the esophagus. A ...
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
... Aaron manufactures two groups of flexible lighting ... and non-sterile in three different sizes 5", ... shaft portion of the light). These lights ... light is needed., ,The second group ...
... manufactures two groups of flexible lighting products. ... non-sterile in three different sizes 5", 10", ... portion of the light). These lights are ... is needed., ,The second group of ...
Medicine Products: